Recent Advances in System Based Study for Anti-Malarial Drug Development Process.

Area of Science:

• Computational biology
• Drug discovery
• Parasitology

Background:

• Malaria remains a significant global health threat, particularly in Africa, Asia, and the Americas, with emerging presence in Europe.
• Existing antimalarial treatments face challenges due to parasite resistance and a lack of sufficiently safe and affordable therapeutic options.
• There is an urgent need for novel antimalarial drug development to address these limitations and combat resistant strains.

Purpose of the Study:

• To review recent advancements in system biology-based approaches for designing and discovering novel antimalarial inhibitors.
• To highlight the potential of systems biology in overcoming challenges in current antimalarial drug discovery.

Main Methods:

• Comprehensive literature survey on malaria persistence, current treatments, and drug discovery shortcomings.
• In-depth analysis of system biology applications in drug discovery, specifically for antimalarial development.
• Review of computational advances including next-generation sequencing, molecular modeling, and docking.

Main Results:

• System-based analysis facilitates understanding of large-scale sequencing data and gene expression in malaria.
• This approach aids in identifying candidate genes and designing drug molecules complementary to target proteins.
• Computational tools enable the identification of potential antimalarial drug candidates.

Conclusions:

• System biology and network biology approaches offer a modern strategy for antimalarial drug discovery and development.
• Computational advances are pivotal in identifying and designing novel antimalarial compounds.
• Integrating these approaches can accelerate the development of safe, affordable, and effective antimalarial therapies.